Can you provide the last earnings date for DMK PHARMACEUTICALS CORP?
DMK PHARMACEUTICALS CORP (DMK) last reported earnings on 11/14/2023.
DMK PHARMACEUTICALS CORP (DMK) Earnings History & Surprises
NASDAQ:DMK • US00547W3079
Current stock price
0.232 USD
+0 (+0.91%)
At close:
0.1665 USD
-0.07 (-28.23%)
After Hours:
DMK Earnings overview
Past quarterly earnings results for DMK PHARMACEUTICALS CORP (DMK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 14, 2024
- Period
- Q4 / 2023
- EPS Estimate
- -$0.42
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 14, 2023
- Period
- Q3 / 2023
- EPS Reported
- -$0.25
- EPS Surprise
- %
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.25 | - | - | 9.06K | - | -99.40% | ||
| Q2 2023 | - | - | 10K | - | 120.00% | |||
| Q1 2023 | - | - | 1.45M | - | 26.09% | |||
| Q4 2022 | - | - | 2.15M | - | 276.23% | |||
| Q3 2022 | - | - | 1.51M | - | 98.68% | |||
| Q2 2022 | -4.20 | -2.47 | -69.73% | -6,900.00% | -50K | 1.028M | -104.86% | -103.91% |
| Q1 2022 | -4.90 | -2.12 | -131.02% | -3,983.33% | 1.15M | - | -17.27% | |
| Q4 2021 | -4.20 | -3.18 | -32.01% | -1,650.00% | -1.22M | 2.846M | -142.87% | -279.41% |
| Q3 2021 | -0.11 | -0.04 | -172.28% | -10.00% | 760K | - | -12.64% | |
| Q2 2021 | -0.06 | -0.06 | -8.01% | 53.85% | 1.28M | 3.123M | -59.01% | 137.32% |
| Q1 2021 | -0.12 | -0.06 | -98.02% | 20.00% | 1.39M | 3.5M | -60.29% | -70.17% |
| Q4 2020 | -0.24 | -0.06 | -296.04% | - | 680K | 5.764M | -88.20% | - |
| Q3 2020 | -0.10 | -0.05 | -85.66% | - | 870K | 7.048M | -87.66% | - |
| Q2 2020 | -0.13 | -0.08 | -67.88% | - | -3.43M | 5.319M | -164.49% | - |
| Q1 2020 | -0.15 | -0.06 | -162.07% | - | 4.66M | 6.46M | -27.86% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
Related analysis
DMK PHARMACEUTICALS CORP / DMK Earnings FAQ
Did DMK stock beat earnings estimates in the most recent quarter?
DMK PHARMACEUTICALS CORP (DMK) missed EPS estimates and missed revenue estimates in the most recent quarter.